Merck sales disappoint as Januvia, Remicade fall short
Go back to Merck sales disappoint as Januvia, Remicade fall short| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.05 | 52 Week High | $77.12 | |||
| Open | $66.05 | 52 Week Low | $49.03 | |||
| Day High | $66.05 | P/E | 42.89 | |||
| Day Low | $66.05 | EPS | $1.54 | |||
| Volume | 16,113 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1225.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1225.73 | 52 Week High | $88.16 | |||
| Open | $1225.73 | 52 Week Low | $67.88 | |||
| Day High | $1225.73 | P/E | 283.73 | |||
| Day Low | $1225.73 | EPS | $4.32 | |||
| Volume | 213,131 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 135.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.17 | 52 Week High | $65.46 | |||
| Open | $135.17 | 52 Week Low | $47.97 | |||
| Day High | $135.17 | P/E | 91.95 | |||
| Day Low | $135.17 | EPS | $1.47 | |||
| Volume | 1,269,534 | |||||
